Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

The Angiogenesis Foundation

Founded in 1994, the Angiogenesis Foundation is the world’s first 501(c)(3) nonprofit organization dedicated to conquering diseases like cancer using a new approach based on angiogenesis, the growth of new capillary blood vessels in the body. We have identified angiogenesis as the “common denominator” in society’s most feared diseases. Our focus on this underlying process of many different diseases makes our approach as a medical organization unique. The Foundation is the recognized, expert voice and champion of this new field of medicine.

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions